Citrullinated Histone H3 and Procalcitonin as Biomarkers for Diagnosing and Predicting Outcomes in Septic Shock - Top-Institutions - MDSpire

Citrullinated Histone H3 and Procalcitonin as Biomarkers for Diagnosing and Predicting Outcomes in Septic Shock

  • By

  • Nadia Mostafa Mohamed

  • Iman Hussein Shehata

  • Amr Hosny Hamza

  • Nermeen M. A. Abdallah

  • March 2, 2026

  • 0 min

Share

Top Institutions in Emergency Medicine

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Infectious Diseases

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Molecular Biology

  • #3

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Infectious Diseases

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Infectious Diseases

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Clinical Pathology

Original Source(s)

Citrullinated Histone H3 and Procalcitonin as Biomarkers for Diagnosing and Predicting Outcomes in Septic Shock

  • by Nadia Mostafa Mohamed, Iman Hussein Shehata, Amr Hosny Hamza, Nermeen M. A. Abdallah

  • March 2, 2026

Related Content

m6A RNA methylation in sepsis-induced cardiomyopathy: direct cardiac mechanisms, emerging therapeutic targets, and translational gaps

Case Report: Severe sepsis due to imported scrub typhus in a German traveler returning from Vietnam

Attenuated hemodynamic response to adjunct vasopressin in obese septic shock patients: a physiological or dose-dependent effect?